908 Devices Inc.
NASDAQ:MASS · NASDAQ Global Market
+$0.22 today
Vol 1.03M · Avg 0.27M
Cash Flow
Check whether earnings turn into cash
Use operating cash flow, capital spending, free cash flow, and financing activity to see how much value is left for reinvestment or owners.
Free Cash Flow
Net Income to FCF bridge
Analysis
Analysis will appear once cash flow data is available for this period.
Cash Flow Statement
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $19.5M +127.0% | -$72.2M -98.4% | -$36.4M -8.4% | -$33.6M -51.4% | -$22.2M | $487.6M | $476.4M | $465.2M |
| Depreciation & Amortization | $3.8M -18.2% | $4.7M +96.4% | $2.4M +47.7% | $1.6M +74.5% | $925.0K | $374.2M | $1.2B | $631.8M |
| Deferred Income Tax | $0 +100.0% | -$283.0K +7.2% | -$305.0K -136.4% | -$129.0K | $0 | $1.4B | -$1.5B | $304.2M |
| Stock-Based Compensation | $9.8M -16.3% | $11.8M +20.2% | $9.8M +35.8% | $7.2M +187.8% | $2.5M | $489.0M | $354.6M | -$1.6B |
| Change in Working Capital | -$15.3M -501.8% | -$2.5M -61.6% | -$1.6M -146.9% | $3.4M +127.0% | -$12.4M | $350.4M | -$1.6B | $1.5B |
| Accounts Receivables | $220.0K +107.5% | -$2.9M -530.4% | $680.0K -88.5% | $5.9M +152.6% | -$11.3M | $592.6M | $1.3B | $626.2M |
| Inventory | -$3.7M -124.2% | -$1.7M +57.4% | -$3.9M +28.7% | -$5.5M -22.2% | -$4.5M | $1.0B | $1.2B | $1.1B |
| Accounts Payables | -$5.9M | $0 | $0 | $0 -100.0% | $2.8M | $948.2M | -$1.5B | $433.0M |
| Other Working Capital | -$5.9M -385.7% | $2.0M +24.3% | $1.6M -43.2% | $2.9M +411.8% | $567.0K | $567.4M | $1.3B | $601.0M |
| Other Non-Cash Items | -$41.6M -246.6% | $28.3M +2606.7% | $1.0M +79.3% | $584.0K -72.1% | $2.1M | $1.4B | -$1.5B | $300.0M |
| Operating Cash Flow | -$23.7M +21.7% | -$30.2M -20.7% | -$25.1M -19.7% | -$20.9M +28.0% | -$29.1M | $7.2B | $8.9B | $10.5B |
| Capital Expenditures | -$955.0K -58.6% | -$602.0K +70.6% | -$2.0M +0.0% | -$2.0M -177.5% | -$737.0K | $664.0M | $1.4B | $697.6M |
| Acquisitions (Net) | -$2.0M +95.5% | -$44.8M | $0 +100.0% | -$13.8M | $0 | $937.0M | $1.1B | $1.3B |
| Purchases of Investments | -$64.0M -15.3% | -$55.5M -13.6% | -$48.9M | $0 | $0 | $444.2M | $1.4B | $1.3B |
| Sales of Investments | $47.8M -12.4% | $54.6M +122.5% | $24.5M | $0 | $0 | $822.2M | $318.2M | -$1.5B |
| Other Investing Activities | $69.9M | $0 | $0 | $0 | $0 | $616.4M | $370.0M | $1.2B |
| Investing Cash Flow | $50.7M +209.6% | -$46.3M -75.5% | -$26.4M -67.0% | -$15.8M -2044.8% | -$737.0K | $4.8B | $6.4B | $5.1B |
| Debt Repayment | $0 | $0 +100.0% | -$15.0M | $0 +100.0% | -$39.0K | $680.8M | $759.2M | $1.1B |
| Common Stock Issued | $864.0K -24.6% | $1.1M +22.4% | $936.0K -39.7% | $1.6M +82.3% | $852.0K | $778.8M | $946.8M | $812.4M |
| Common Stock Repurchased | $0 | $0 | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $535.2M | $613.6M | $692.0M |
| Other Financing Activities | -$1.6M -2.6% | -$1.5M +18.7% | -$1.9M -400.3% | -$374.0K -100.4% | $93.9M | -$1.6B | $1.3B | $1.1B |
| Financing Cash Flow | -$697.0K -85.4% | -$376.0K +97.6% | -$15.9M -1451.6% | $1.2M -98.8% | $94.7M | $12.2B | $13.9B | -$15.5B |
| Effect of Forex Changes | $27.0K +141.5% | -$65.0K -600.0% | $13.0K -27.8% | $18.0K | $0 | $1.3B | $1.1B | $990.2M |
| Net Change in Cash | $26.4M +134.3% | -$77.0M -14.3% | -$67.4M -89.6% | -$35.5M -154.8% | $64.9M | $3.2B | $4.9B | $6.5B |
| Free Cash Flow | -$24.6M +20.1% | -$30.8M -13.8% | -$27.1M -18.0% | -$23.0M +23.0% | -$29.8M | $8.6B | -$16.8B | $11.1B |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Capricor Therapeutics, Inc.
NASDAQ:CAPR
$1.30B
Aclaris Therapeutics, Inc.
NASDAQ:ACRS
$537.25M
Cerus Corporation
NASDAQ:CERS
$536.79M
NeuroPace, Inc.
NASDAQ:NPCE
$521.63M
Sight Sciences, Inc.
NASDAQ:SGHT
$280.13M
Senseonics Holdings, Inc.
NASDAQ:SENS
$276.68M
Quanterix Corporation
NASDAQ:QTRX
$151.45M
CVRx, Inc.
NASDAQ:CVRX
$131.62M
Nano-X Imaging Ltd.
NASDAQ:NNOX
$120.39M
SANUWAVE Health, Inc.
NASDAQ:SNWV
$81.00M
SEC Filings
Recent regulatory filings
No filings found.
Does MASS generate free cash flow?
908 Devices Inc. (MASS) generated -$24,643,000.00 of free cash flow in fiscal 2025.
How much operating cash flow does MASS produce?
Operating cash flow was -$23,688,000.00, before capital expenditures of $955,000.00.
Explore More
Continue the stock analysis
Jump to another research area for this company.